# Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

> **NCT03958409** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 8 (actual)

## Conditions studied

- Skeletal Anomalies
- Kidney Transplant; Complications

## Interventions

- **DIAGNOSTIC_TEST:** measurements to evaluate metabolic bone disease
- **DIAGNOSTIC_TEST:** standard care

## Key facts

- **NCT ID:** NCT03958409
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-12
- **Primary completion:** 2021-12-02
- **Final completion:** 2021-12-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03958409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03958409, "Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03958409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*